Immunohistochemistry of INI1 expression: A new tool for old challenges in CNS and soft tissue pathology

Advances in Anatomic Pathology

Volumn 14, Issue 5, 2007, Pages 335-339

  Judkins, Alexander R ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

AT RT; Atypical teratoid rhabdoid tumor; BAF47; Epithelioid sarcoma; hSNF5; INI1; Rhabdoid tumors; SMARCB1

Indexed keywords

EPITHELIAL MEMBRANE ANTIGEN; SMOOTH MUSCLE ACTIN; TUMOR MARKER;

ANTIBODY LABELING; ANTIBODY PRODUCTION; BRAIN TUMOR; CARBOXY TERMINAL SEQUENCE; CENTRAL NERVOUS SYSTEM TUMOR; DIAGNOSTIC ACCURACY; GENE; GENE DELETION; GENE EXPRESSION; GENE INACTIVATION; GENE INI1; GENE MUTATION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MEDULLOBLASTOMA; MOLECULAR GENETICS; NERVE SHEATH TUMOR; NEUROECTODERM TUMOR; PRIORITY JOURNAL; REVIEW; RHABDOID TUMOR; SARCOMA; SOFT TISSUE TUMOR;

ANIMALS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; SOFT TISSUE NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 34548185214     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e3180ca8b08     Document Type: Review

References (20)

1. Versteege I, Sevenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature. 1998;394:203-206.
2. Biegel JA. Molecular genetics of atypical teratoid/rhabdoid tumor. Neurosurg Focus. 2006;20:E11.
3. Roberts CW, Orkin SH. The SWI/SNF complex - chromatin and cancer. Nat Rev Cancer. 2004;4:133-142.
4. Rorke LB, Packer RJ, Biegel JA. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg. 1996;85:56-65.
5. Imbalzano AN, Jones SN. Snf5 tumor suppressor couples chromatin remodeling, checkpoint control, and chromosomal stability. Cancer Cell. 2005;7:294-295.
6. Biegel JA, Tan L, Zhang F, et al. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res. 2002;8:3461-3467.
7. Haberler C, Laggner U, Slavc I, et al. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Am J Surg Pathol. 2006;30:1462-1468.
8. Judkins AR, Mauger J, Ht A, et al. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol. 2004;28:644-650.
9. Perry A, Fuller CE, Judkins AR, et al. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. Mod Pathol. 2005;18:951-958.
10. Bourdeaut F, Freneaux P, Thuille B, et al. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. J Pathol. 2007;211:323-330.
11. Judkins AR, Burger PC, Hamilton RL, et al. INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. J Neuropathol Exp Neurol. 2005;64:391-397.
12. Raisanen J, Biegel JA, Hatanpaa KJ, et al. Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults. Brain Pathol. 2005;15:23-28.
13. Sigauke E, Rakheja D, Maddox DL, et al. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis. Mod Pathol. 2006;19:717-725.
14. Hoot AC, Russo P, Judkins AR, et al. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol. 2004;28:1485-1491.
15. Laskin WB, Miettinen M. Epithelioid sarcoma: new insights based on an extended immunohistochemical analysis. Arch Pathol Lab Med. 2003;127:1161-1168.
16. Guillou L, Wadden C, Coindre JM, et al. "Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series. Am J Surg Pathol. 1997;21:130-146.
17. Lualdi E, Modena P, Debiec-Rychter M, et al. Molecular cytogenetic characterization of proximal-type epithelioid sarcoma. Genes Chromosomes Cancer. 2004;41:283-290.
18. Modena P, Lualdi E, Facchinetti F, et al. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res. 2005;65:4012-4019.
19. Kreiger P, Judkins A, Russo PA, et al. INI1 protein loss in tumors with a non-rhabdoid phenotype. Society for Pediatric Pathology Spring 2006 Meeting. Atlanta GA, 2006.
20. Allen JC, Judkins AR, Rosenblum MK, et al. Atypical teratoid/ rhabdoid tumor evolving from an optic pathway ganglioglioma: case study. Neurooncology 2006;8:79-82.